Nice! I see the SGH (not Slater and Gordon LOL) microcap fund has taken a keen interest in this company. it's very promising to have a company of that stature buying aggressively on market (almost half of the trading volume on the 25th) on the back of the Carrick independent clinical trial .
Here is a little about them:
"Our high-conviction active management approach is founded on our ValueActiveTM investment process – used by the team for more than a decade. It combines in depth valuation analysis with a forensic approach to company research, market fundamentals and insight. Simply put, we like to buy great sustainable companies at attractive prices."
"In order to identify the best opportunities for our clients, we undertake a broad fundamental research program which incorporates an extensive company visitation schedule. With an experienced team of investment professionals, our approach to analysing companies is designed to ensure no stone remains unturned."
"We engage with a hand picked team of external research providers to complement our insights in the macroeconomic landscape (both locally and abroad) and general investment trends. We also have an exclusive joint advisory arrangement with one of the world’s largest commercial real estate investors; LaSalle Investment Management Securities, LLC is a subsidiary of global property giant, Jones Lang LaSalle. This provides our property team access to LaSalle’s research capabilities."
LOL) microcap fund has taken a keen interest in this company. it's very promising to have a company of that stature buying aggressively on market (almost half of the trading volume on the 25th) on the back of the Carrick independent clinical trial .
